1-6 of 6
James Huber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In vitro characterization and in vivo anti-tumor activity of human monoclonal antibodies to the RON-receptor tyrosine kinase

Free
Jennifer O'Toole, Erik Corcoran, Wenzhi Tian, James Huber, Pinki Singh, James Tonra, Yan Wu, Dale Ludwig, Yaron Hadari, Nick Loizos
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3984.
Published: 01 May 2008
View articletitled, In vitro characterization and in vivo anti-tumor activity of human monoclonal antibodies to the RON-receptor tyrosine kinase
Journal Articles

Synergistic anti-tumor effects of anti-EGFR monoclonal antibody Erbitux® combined with antibodies targeting IGF1R or VEGFR-2

Free
James R. Tonra, Erik Corcoran, Genevieve Makhoul, Douglas Burtrum, Bridget Finnerty, James Huber, Francine E. Carrick, Dale L. Ludwig, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1193.
Published: 01 May 2005
View articletitled, Synergistic anti-tumor effects of anti-EGFR monoclonal antibody Erbitux® combined with antibodies targeting IGF1R or VEGFR-2
Journal Articles

Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies

Free
Guido Bocci, Shan Man, Shane K. Green, Giulio Francia, John M. L. Ebos, Jeanne M. du Manoir, Adina Weinerman, Urban Emmenegger, Li Ma, Philip Thorpe, Andrew Davidoff, James Huber, Daniel J. Hicklin, Robert S. Kerbel
Journal: Cancer Research
Cancer Res (2004) 64 (18): 6616–6625.
https://doi.org/10.1158/0008-5472.CAN-04-0401
Published: 16 September 2004
View articletitled, Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies
Open the PDF for Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies in another window
Journal Articles

A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers

Free
Yan Wu, Zhaojing Zhong, Huiling Li, James Huber, Rajiv Bassi, Andrea Hooper, Bridget Finnerty, Xenia Jimenez, Henry Koo, Paul Balderes, Dale Ludwig, Paul Kussie, Larry Witte, Peter Bohlen, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 694–695.
Published: 01 April 2004
View articletitled, A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers
Journal Articles

Responses to Antiangiogenesis Treatment of Spontaneous Autochthonous Tumors and Their Isografts

Free
Yotaro Izumi, Emmanuelle di Tomaso, Andrea Hooper, Peigen Huang, James Huber, Daniel J. Hicklin, Dai Fukumura, Rakesh K. Jain, Herman D. Suit
Journal: Cancer Research
Cancer Res (2003) 63 (4): 747–751.
Published: 15 February 2003
View articletitled, Responses to Antiangiogenesis Treatment of Spontaneous Autochthonous Tumors and Their Isografts
Open the PDF for Responses to Antiangiogenesis Treatment of Spontaneous Autochthonous Tumors and Their Isografts in another window
Journal Articles

Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors

Free
Marie Prewett, James Huber, Yiwen Li, Angel Santiago, William O’Connor, Karen King, Jay Overholser, Andrea Hooper, Bronislaw Pytowski, Larry Witte, Peter Bohlen, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (1999) 59 (20): 5209–5218.
Published: 01 October 1999
View articletitled, Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors
Open the PDF for Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors in another window